LOW-DOSE SUBCUTANEOUS HEPARIN VERSUS ORAL ANTICOAGULANTS IN THE PREVENTION OF POSTOPERATIVE DEEP-VENOUS THROMBOSIS: A Controlled Clinical Trial
- 9 March 1974
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 303 (7854), 375-378
- https://doi.org/10.1016/s0140-6736(74)93147-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Small Subcutaneous Doses of Heparin in Prevention of Venous ThrombosisNew England Journal of Medicine, 1973
- SMALL DOSES OF SUBCUTANEOUS SODIUM HEPARIN IN PREVENTING DEEP VENOUS THROMBOSIS AFTER MAJOR SURGERYThe Lancet, 1972
- EFFICACY OF LOW DOSES OF HEPARIN IN PREVENTION OF DEEP-VEIN THROMBOSIS AFTER MAJOR SURGERYThe Lancet, 1972
- CONTROLLED TRIAL OF TWO REGIMENS OF SUBCUTANEOUS HEPARIN IN PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSISThe Lancet, 1972
- The Diagnosis of Deep Vein Thrombosis Using the 125I Fibrinogen TestArchives of Surgery, 1972
- 125I-LABELLED FIBRINOGEN TEST ADAPTED FOR ROUTINE SCREENING FOR DEEP-VEIN THROMBOSISThe Lancet, 1970
- Safe per-operative anticoagulationThorax, 1967
- DETECTION OF VENOUS THROMBOSIS IN THE LEGSThe Lancet, 1965
- PREVENTION OF VENOUS THROMBOSIS AND PULMONARY EMBOLISM IN INJURED PATIENTS: A Trial of Anticoagulant Prophylaxis with Phenindione in Middle-aged and Elderly Patients with Fractured Necks of FemurThe Lancet, 1959